99 A new study highlights the challenges of diagnosing intraocular schwannoma, a rare benign eye tumour that often presents similarly to more dangerous conditions like uveal melanoma. The research, conducted at Beijing Tongren Hospital, examined 28 cases of intraocular schwannoma and offers insight into the clinical features and difficulties in distinguishing this tumour from malignant ones. The findings were published in the journal Eye. Intraocular schwannoma is a benign tumour originating from the Schwann cells of the ciliary nerves. These tumours, which primarily affect the eye’s ciliary body and choroid, are extremely rare, and their presentation can easily be confused with amelanotic uveal melanoma. Both conditions involve non-pigmented tumours, which can complicate clinical diagnosis, often requiring histopathological examination to confirm the tumour’s true nature. The study found that the most common symptom among the patients was visual loss, with 75% of them reporting this as their primary issue. The median age of the patients was 39, with an even gender distribution. Notably, the tumours were most frequently located in the ciliary body, followed by the choroid and ciliochoroid. However, the most concerning aspect of the research is how frequently intraocular schwannoma was clinically misdiagnosed as uveal melanoma. Of the 28 cases studied, over half were initially believed to be melanoma, leading to unnecessary stress and treatment delays for patients. Diagnostic challenges are compounded by the limitations of standard imaging techniques. Ultrasounds and MRI scans, often used to examine the eye, do not always distinguish intraocular schwannoma from other tumours like melanoma or haemangioma. In the study, nearly 60% of patients underwent surgery to excise the tumour based on a preliminary diagnosis of melanoma, only to find upon further testing that it was, in fact, schwannoma. While intraocular schwannoma is not life-threatening, proper and timely diagnosis is critical. Without treatment, these tumours can grow, leading to significant vision loss. Surgical resection, often involving pars plana vitrectomy or transscleral resection, has proven effective in managing the condition. During the follow-up period, which spanned several years, none of the patients in this study experienced recurrence or metastasis of the tumour. The rarity of this tumour adds to the difficulty of ensuring prompt and accurate diagnoses. The researchers also reviewed a range of literature on intraocular schwannoma, consolidating data from 49 previously reported cases. Despite the variability in reported tumour sizes and locations, the overall prognosis for patients diagnosed with intraocular schwannoma is positive, with no instances of malignant transformation recorded.